Martin Diggle Purchases 119,636 Shares of Proteome Sciences plc (PRM) Stock
Proteome Sciences plc (LON:PRM) insider Martin Diggle bought 119,636 shares of the business’s stock in a transaction dated Friday, October 20th. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £3,589.08 ($4,768.91).
Martin Diggle also recently made the following trade(s):
- On Wednesday, October 18th, Martin Diggle bought 256,520 shares of Proteome Sciences plc stock. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £7,695.60 ($10,225.35).
Proteome Sciences plc (LON:PRM) traded up 2.21% during trading on Monday, reaching GBX 3.24. The company had a trading volume of 311,904 shares. The firm’s market capitalization is GBX 9.54 million. Proteome Sciences plc has a 12-month low of GBX 2.61 and a 12-month high of GBX 11.12. The firm’s 50 day moving average price is GBX 3.49 and its 200 day moving average price is GBX 4.18.
ILLEGAL ACTIVITY WARNING: This article was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.americanbankingnews.com/2017/10/23/martin-diggle-purchases-119636-shares-of-proteome-sciences-plc-prm-stock.html.
Separately, FinnCap restated a “corporate” rating and issued a GBX 12 ($0.16) target price on shares of Proteome Sciences plc in a research note on Friday, June 30th.
Proteome Sciences plc Company Profile
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications.
Receive News & Ratings for Proteome Sciences plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences plc and related companies with MarketBeat.com's FREE daily email newsletter.